Synthetic Biologics, Inc. (NYSE: SYN) today announced it has entered into an agreement with Cedars-Sinai Medical Center for an investigator-sponsored ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE